AVROBIO, Inc. Expands Rare Disease Pipeline with Gene Therapy to Treat Pompe Disease – Business Wire (press release)
|
AVROBIO, Inc. Expands Rare Disease Pipeline with Gene Therapy to Treat Pompe Disease
Business Wire (press release) CAMBRIDGE, Mass.–(BUSINESS WIRE)–AVROBIO, Inc., a clinical-stage biotechnology company developing transformative, life-changing gene therapies for rare diseases, today announced the expansion of its pipeline to Pompe disease. This pre-clinical … |
